Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220778852> ?p ?o ?g. }
- W4220778852 endingPage "1867" @default.
- W4220778852 startingPage "1857" @default.
- W4220778852 abstract "Phenylalanine ammonia lyase (PAL) metabolizes phenylalanine to transcinnamic acid (TCA). Our eventual goal is to develop a PAL microcapsule formulation to deplete phenylalanine in the gastrointestinal tract (g.i.t). The focus of this research is pre-formulation studies with PAL. PAL exhibited undesirable time dependent decrease in activity due to TCA mediated product inhibition. Addition of bovine serum albumin (BSA) completely relieved product inhibition. Ultrafiltration experiments revealed that BSA acted by binding and sequestering TCA. PAL exhibits maximum activity at a pH of 8.5 and will need to be buffered to retain activity in the g.i.t. Buffer studies showed that a pH 8.5, 0.4 M Bicine buffer containing BSA was able to maintain maximal PAL activity against simulated gastric and intestinal fluid additions. Buffered PAL with BSA was able to rapidly and completely deplete phenylalanine in simulated mouse g.i.t conditions. A small fraction of phenylalanine in the g.i.t is present as dipeptides. Our studies established for the first time that PAL cannot metabolize phenylalanine dipeptides. Our results explain why previous trials with PAL in the management of phenylketonuria produced low efficacy. They will guide design of a PAL microcapsule formulation that maintains maximal PAL activity during its transit through the g.i.t." @default.
- W4220778852 created "2022-04-03" @default.
- W4220778852 creator A5004725511 @default.
- W4220778852 creator A5032354015 @default.
- W4220778852 creator A5045151870 @default.
- W4220778852 creator A5052901014 @default.
- W4220778852 creator A5067571739 @default.
- W4220778852 creator A5073114289 @default.
- W4220778852 creator A5076374988 @default.
- W4220778852 creator A5086387942 @default.
- W4220778852 date "2022-07-01" @default.
- W4220778852 modified "2023-10-06" @default.
- W4220778852 title "Preformulation Studies with Phenylalanine Ammonia Lyase: Essential Prelude to a Microcapsule Formulation for the Management of Phenylketonuria" @default.
- W4220778852 cites W1513692286 @default.
- W4220778852 cites W1553515065 @default.
- W4220778852 cites W1589858311 @default.
- W4220778852 cites W1635281797 @default.
- W4220778852 cites W1970091480 @default.
- W4220778852 cites W1975586699 @default.
- W4220778852 cites W1976715411 @default.
- W4220778852 cites W1982795414 @default.
- W4220778852 cites W1990164608 @default.
- W4220778852 cites W1990452979 @default.
- W4220778852 cites W1990591430 @default.
- W4220778852 cites W1993097977 @default.
- W4220778852 cites W1998831401 @default.
- W4220778852 cites W2017654147 @default.
- W4220778852 cites W2018628343 @default.
- W4220778852 cites W2019390894 @default.
- W4220778852 cites W2027363017 @default.
- W4220778852 cites W2044499660 @default.
- W4220778852 cites W2046252579 @default.
- W4220778852 cites W2047030426 @default.
- W4220778852 cites W2049056290 @default.
- W4220778852 cites W2050384029 @default.
- W4220778852 cites W2050775539 @default.
- W4220778852 cites W2054480634 @default.
- W4220778852 cites W2054915953 @default.
- W4220778852 cites W2061769480 @default.
- W4220778852 cites W2065933439 @default.
- W4220778852 cites W2073907027 @default.
- W4220778852 cites W2075243461 @default.
- W4220778852 cites W2075788325 @default.
- W4220778852 cites W2077675998 @default.
- W4220778852 cites W2079494761 @default.
- W4220778852 cites W2084227241 @default.
- W4220778852 cites W2085642525 @default.
- W4220778852 cites W2089407496 @default.
- W4220778852 cites W2092277696 @default.
- W4220778852 cites W2092487182 @default.
- W4220778852 cites W2099620259 @default.
- W4220778852 cites W2101982331 @default.
- W4220778852 cites W2105022185 @default.
- W4220778852 cites W2105439184 @default.
- W4220778852 cites W2107167014 @default.
- W4220778852 cites W2116480504 @default.
- W4220778852 cites W2133545438 @default.
- W4220778852 cites W2137245183 @default.
- W4220778852 cites W2138701893 @default.
- W4220778852 cites W2147153727 @default.
- W4220778852 cites W2147296837 @default.
- W4220778852 cites W2150567145 @default.
- W4220778852 cites W2162050340 @default.
- W4220778852 cites W2192861754 @default.
- W4220778852 cites W2200991233 @default.
- W4220778852 cites W2210581388 @default.
- W4220778852 cites W2328379097 @default.
- W4220778852 cites W2339263402 @default.
- W4220778852 cites W2405429551 @default.
- W4220778852 cites W2620127880 @default.
- W4220778852 cites W2759453173 @default.
- W4220778852 cites W2771328888 @default.
- W4220778852 cites W2892532239 @default.
- W4220778852 cites W2949888206 @default.
- W4220778852 cites W32260961 @default.
- W4220778852 cites W4249791806 @default.
- W4220778852 doi "https://doi.org/10.1016/j.xphs.2022.03.016" @default.
- W4220778852 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35351497" @default.
- W4220778852 hasPublicationYear "2022" @default.
- W4220778852 type Work @default.
- W4220778852 citedByCount "2" @default.
- W4220778852 countsByYear W42207788522022 @default.
- W4220778852 countsByYear W42207788522023 @default.
- W4220778852 crossrefType "journal-article" @default.
- W4220778852 hasAuthorship W4220778852A5004725511 @default.
- W4220778852 hasAuthorship W4220778852A5032354015 @default.
- W4220778852 hasAuthorship W4220778852A5045151870 @default.
- W4220778852 hasAuthorship W4220778852A5052901014 @default.
- W4220778852 hasAuthorship W4220778852A5067571739 @default.
- W4220778852 hasAuthorship W4220778852A5073114289 @default.
- W4220778852 hasAuthorship W4220778852A5076374988 @default.
- W4220778852 hasAuthorship W4220778852A5086387942 @default.
- W4220778852 hasConcept C181199279 @default.
- W4220778852 hasConcept C185592680 @default.
- W4220778852 hasConcept C2777431362 @default.
- W4220778852 hasConcept C2778112864 @default.
- W4220778852 hasConcept C43617362 @default.
- W4220778852 hasConcept C515207424 @default.